Stryker (SYK) Non Operating Interest Expenses (2025 - 2026)
Stryker's (SYK) quarterly Non Operating Interest Expenses came in at $141.0 million in Q2 2026, down 11.32% year-over-year from $159.0 million in Q2 2025, and down 4.73% quarter-over-quarter from $148.0 million in Q1 2026.
Powered by 
Analysis
Stryker (SYK) Non Operating Interest Expenses (2025 - 2026) Analysis & Trends
Stryker (SYK) has reported Non Operating Interest Expenses for 2 consecutive years, with $141.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses fell 11.32% year-over-year to $141.0 million in Q2 2026; TTM through Jun 2026 was $585.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $607.0 million, up 48.41% from the prior year.
- Non Operating Interest Expenses was $141.0 million for Q2 2026 at Stryker, down from $148.0 million in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $159.0 million in Q2 2025 and troughed at $137.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141.00 Mn |
| Mar 31, 2026 | 148.00 Mn |
| Jun 30, 2025 | 159.00 Mn |
| Mar 31, 2025 | 137.00 Mn |